D-Street Buzz: Pharma stocks gain led by Sun Pharma, Biocon; CLSA picks DRL, downgrades Aurobindo Pharma
CLSA has a buy on Sun Pharma, Cadila Healthcare and Dr Reddy’s Labs and has a sell on Biocon and Lupin. The research firm has downgraded Aurobindo Pharma to underperform from outperform. January 08, 2021 / 11:33 AM IST
Vaishali Pharma | Manju Jayantilal Lodha sold 1,21,952 equity shares in company at Rs 74.81 per share on the NSE.
The Indian stock market continues trading in the green with Sensex up 373.22 points or 0.78 percent at 48466.54, and the Nifty added 125 points or 0.88 percent at 14262.40.
Among the sectors, the pharma index gained over a percent led by Sun Pharma and Biocon which gained 2 percent each followed by Torrent Pharma, Lupin, Dr Reddy s Labs, Cipla and Divis Labs.